CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for 9 Meters Biopharma Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

9 Meters Biopharma Inc
4509 CREEDMOOR ROAD, SUITE 600
Phone: (919) 275-1933p:919 275-1933 RALEIGH, NC  27612  United States Ticker: NMTRQNMTRQ
Filed for Bankruptcy on 7/17/2023
Case #23-01992, filed in the U.S. Bankruptcy Court for the Eastern District of North Carolina (Raleigh Division) (Chapter 7)
Business Summary
9 Meters Biopharma, Inc. has ceased operations. The Company has filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the Bankruptcy Code) in the United States Bankruptcy Court for the Eastern District of North Carolina.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202312/31/2022YesYes--Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board MarkSirgo 69 4/30/2020 4/30/2020
Interim Chief Executive Officer, Chief Financial Officer Bethany L.Sensenig 47 5/26/2023 1/18/2022
Independent Director Michael T.Constantino 60 6/30/2020 6/30/2020
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Innovate Biopharmaceuticals, Inc.
INNT
Monster Digital, Inc.
7 additional Business Names available in full report.

General Information
Number of Employees: 10 (As of 12/31/2022)
Outstanding Shares: 14,459,690 (As of 5/12/2023)
Shareholders: 142
Stock Exchange: OTC
Federal Tax Id: 273948465
Fax Number: (302) 636-5454


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, November 17, 2024